Login to Your Account


BUENOS AIRES, Argentina – Plantpraxis – a melding of Axis Biotech Brasil, of Rio de Janeiro, and Canadian biotech Plantform Corp. – is on track to dent the costs of expensive biologic treatments in developing countries, according to Axis CEO Eduardo Cruz.

HONG KONG – To speed up biopharmaceutical research on fighting superbugs, the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator recently awarded grants to a number of biopharma firms, among them a 3-year-old startup aptly named Bugworks Research India Pvt. Ltd., which received $2.6 million.

HONG KONG – With $13.2 million in new financing, Tokyo-based oncology drug developer Anaeropharma Science Inc. now plans to focus on research and development of drug candidates that target hypoxic microenvironments of tumors by using recombinant Bifidobacterium.

More Newco News Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: